CureVac
A biopharmaceutical company developing prophylactic and therapeutic application of messenger RNA, which can be used to develop vaccines. It was founded in 2000 and is located in Tübingen, Germany.
Key facts
| AngelList URL | https://angel.co/curevac |
|---|---|
| Blog | https://www.owler.com/company/curevac#blog |
| Business Model | Commerce |
| Legal Name | CureVac N.V. |
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/curevac#section-overview |
| Facebook URL | https://www.facebook.com/CureVac/ |
| Full Address | 250 Summer St 3rd Fl Boston, MA 02210, USA |
| LinkedIn URL | https://www.linkedin.com/company/curevac/ |
| Pitchbook URL | https://pitchbook.com/profiles/company/55268-20 |
| Previous Name | CureVac B.V. |
| Stock Symbol | CVAC |
| Ticker Symbol | CVAC |
| Twitter URL | https://twitter.com/CureVacRNA |
| Official Website | https://curevac.com/en |
| Wellfound ID | curevac |
| Wikidata ID | Q1144473 |
| YouTube Channel | https://www.youtube.com/channel/UCtwge2rdqHr50rxnf45ltcw |
Contact details
Email and phone for CureVac are available to signed-in members of PharmaLyt.
Sign in to view